临床路径在单病种费用包干管理中的应用  

Application of clinical pathway in the management of single disease cost

作　　者：蒋冬梅[1] 姜萍岚[1] 虞玲丽[1] 赖娟[2] 李亚平[1] 唐利立[1] 

机构地区：[1]中南大学湘雅医院,长沙410008 [2]中南大学护理学院

出　　处：《中国实用护理杂志（中旬版）》2008年第5期4-6,共3页Chinese Journal of Practical Nursing

基　　金：湖南省卫生厅科研课题资助项目（B2004-026）

摘　　要：目的研究临床路径管理模式在单病种费用包干中的应用。方法将2006年6月-2007年6月在中南大学湘雅医院乳腺科住院的患者随机分成2组，医保单病种费用包干患者为实验组，非医保单病种费用包干患者为对照组，2组均为40例，均为女性，2组入选患者的年龄、肿瘤部位、疾病分期、手术方式比较差异均无统计学意义。包干组按制订好的临床路径管理模式工作，非包干组按常规医疗护理模式工作。结果包干组的平均住院日、平均候手术日、平均住院费用均低于非包干组（P〈0．05），包干组的健康知识掌握度、患者的满意度高于非包干组（P〈0．05）。结论对医保费用包干患者实施临床路径管理能有效控制费用和保证质量，认为单病种患者实施费用包干是切实可行的。Objective To explore the application of clinical pathway in the management of single disease cost. Methods Inpatients with breast cancer from June 2006 to June 2007 were divided into the test group and the control group according to different payment models.Patients in the test group had medical insurance while patients in the control group did not.The general data in the two groups had no statistical difference. The test group were given nursing intervention by clinical pathway while the control group received routine nursing measures. Results The mean inhospital days,mean days waiting for operations and mean inhospital expenses in the test group were shorter or lower than those in the control group （P 〈 0.05）.The mastering degree of health knowledge and the satisfaction degree of patients in the test group were higher than those in the control group （P 〈 0.05）. Conclusions The application of clinical pathway in the single disease cost patients with medical insurance could effectively control the medical expenses and guarantee the quality.So we consider that the application of clinical pathway in single disease cost is applicable.

关 键 词：临床路径 单病种 费用包干 

分 类 号：R197.323[医药卫生—卫生事业管理] R197.63[医药卫生—公共卫生与预防医学]